After intradermal (id) injection, the line-IO hepatoma grew progressively in nonimmune guinea pigs, whereas the line-l hepatoma grew for approximately 2 weeks, developed central necrosis, ulcerated, and regressed_ Growth of the line-IO hepatoma was suppressed when line-IO hepatoma cells were mixed with antigenically distinct line-l hepatoma cells before id injection into syngeneic strain-2 guinea pigs. Mixture of line-IO with irradiated line-lor viable strain-2 embryo cells did not inhibit tumor growth_ Preimmunization of recipients to line-l cells abrogated the suppression of tumor growth from mixtures of line-l and line-10.-J Natl Cancer Inst 55: 989-994, 1975. 1 
Established tumors regressed at sites of primary infection with BCG (1) Corynebacteria sp. (2) , Listeria monocytogenes (3) , and vaccinia (4) . Local inhibition of tumor growth has been associated with an anamnestic response to purified protein derivative of tuberculin (PPD) (5) and to compounds that can induce contact hypersensitivity (5, 6) . The administration of immunotherapeutic agents at distant sites did not affect tumor growth, and it has been postulated that tumor cells are killed, at least in part, as "bystanders" at sites of local inflammation. Support for this theory has been gathered from in vitro studies in which lymphocytes and macrophages, stimulated by non tumorous antigens or by mitogens, inhibited the growth of normal and neoplastic cells (7) (8) (9) (10) (11) (12) (13) (14) .
The relevance of in vitro studies has been challenged by repeated failure to inhibit syngeneic tumor growth in vivo at sites of a primary or anamnestic response to allogeneic murine carcinomas and sarcomas (15) (16) (17) (18) . By contrast, studies of guinea pigs and mice (19, 20) demonstrated that syngeneic tumor cells can be killed at the site of an anamnestic response to a second antigenically distinct syngeneic tumor line. A recent report suggests that a primary response to xenogeneic rat tumor cells may suppress murine tumor growth (21) . Use of a strongly immunogenic guinea pig hepatoma has permitted comparison of the antitumor activity of a primary and an anamnestic response to tumor-associated transplantation antigen(s) in syngeneic recipients. In this system we found that tumor cells can be killed as bystanders at the site of a primary response to an antigenically distinct syngeneic tumor, but that an anamnestic response fails to suppress bystander growth.
MATERIALS AND METHODS
Animals.-Male Sewall-Wright strain-2 guinea pigs (450-500 g) were obtained from the Laboratory Aids Branch, Division of Research Services, NIH, and from the Animal Breeding Colony, Frederick Cancer Research Center, Frederick, Maryland. Guinea pigs were grouped 6 per cage and fed Wayne guinea pig chow daily and kale three times a week. Tap water was provided ad libitum.
Tumors.-Hepatomas were induced in strain-2 guinea pigs by the oral administration of diethylnitrosamine (22) . Ascites variants of two antigenically distinct tumor lines were maintained by serial ip passage in weanling strain-2 males (22, 23) . Line-I (transplant generations 92-103), a moderately antigenic tumor, grew progressively after im, ip, or iv inoculation, but regressed after intradermal (id) injection. Line-1O (transplant generations 8-18), a weakly antigenic tumor, grew progressively after id injection with 1(}6 cells, metastasized to regional lymph nodes; and killed recipients within 60-90 days.
Preparation of tumor cell suspensions.-Ascites containing tumor cells were removed from donor animals. Cells were sedimented at 200xg for 5 minutes, washed twice in medium 199 (Microbiological Associates, Bethesda, Md.), and resuspended in the same medium. A portion of each tumor cell suspension was diluted 1: 20 in 0.13% try pan blue, and viable cells were enumerated in a hemocytometer.
Irradiation.-In one experiment, line-l tumor cells were exposed to 12,000 R of X-irradiation as described in (24) .
Embryo cells.-Torsos of strain-2 embryos (::::::3.0 cm in crown-rump length) were rinsed three times with cal· cium-magnesium-free Dulbecco's phosphate-buffered sa· line (PBS). Embryos were cut into 1-to 2-mm pieces. Tissue was digested for 15 minutes with 0.25% pronase and 40 {tg/ml DNase in PBS. Digestion was repeated three times: The first batch of cells was discarded and the last two were pooled. Dispersed embryo cells were filtered through two layers of sterile gauze, sedimented at 200xg for 10 minutes at 4° C, washed once in medium 199, and resuspended in the same medium. Cells were enumerated in a hemocytometer after dilution of a sample with 0.13% trypan blue.
Immunization of animals with line-1 tumor cells.-Washed line-1 hepatoma cells were adjusted to 3 X 10 7 /ml in medium 199, and O.l-ml samples of the tumor cell suspension were injected id into the right flanks of the animals. Injection of tumor cells was repeated weekly for 3 weeks. After an additional 2 weeks, animals were rechallenged with 3 X 10 6 line-l tumor cells id. All line-limmune guinea pigs used in these studies developed induration and erythema (at least 7.5 mm in diameter) at the injection site within 24 hours after tumor cell inoculation.
Injection of mixtures containing tumor cells.-Cells were adjusted to appropriate concentrations in medium 199. Mixtures of cells were prepared immediately before id injection; cell mixtures in a volume of 0.1 ml were injected into the left flanks of the guinea pigs. In some experiments, line-IO tumor cells were injected on the left flank and line-l tumor cells on the right flank.
Evaluation of tumor growth.-Tumors and regional lymph nodes were observed weekly for at least 90 days.
The incidence of tumor suppression in different groups was compared statistically by the Fisher exact test. Difference in tumor size was evaluated with the Student's t-test and difference in survival with the Mann-Whitney V-test.
RESULTS

Suppression of Tumor Growth in Nonimmune Guinea Pigs Receiving Mixtures of Line-l and Line-IO Cells
For evaluation of the antitumor activity of a primary immune response to the line-l hepatoma, the animals received an id injection of 1061ine-1O tumor cells mixed with 3X104 to 3XI07 line-l tumor cells (table 1, of 5 guinea pigs given 3x 10 7 line-l tumor cells and in 2 of 4 receiving 3x 10 6 line-I cells. In an additional ani-!1lal in each group, tumor growth was inhibited locally, but these guinea pigs died from progressive lymph node metastases. Smaller numbers of line-I cells failed to affect line-tO tumor growth, either locally or within regional lymph nodes.
After the id injection of 3 X 10 6 or 3 X cells was not effective in suppressing tumor growth. Injection of 3 X 10 5 line-I cells without line-IO cells produced a smaller (8.5 mm) nodule at 14 days. Seven weeks were required for the complete regression of all tumors; central necrosis and ulceration did not develop. Absence of antitumor activity may relate to the smaller amount of line-l antigen or to more gradual tumor inhibition consistent with a less intense immune response to line-I tumor-associated antigens.
The id injection of 3 X 10 7 irradiated line-I tumor cells with 10 6 line-IO cells failed to affect line-IO growth. Strain-2 embryo cells produced a slight, but significant, inhibition of line-IO growth without complete or permanent suppression at the injection site in five recipients (text- fig. 2A, B ). Injection of line-l cells at a separate site on the contralateral flank did not inhibit the line-IO tumor (table 2) . Tumor suppression may require direct contact between line-l and line-IO cells, though this experiment does not rule out the possibility that line-I cells need only be injected within the same general anatomic region to affect line-IO growth. 
-Incidence of progressive growth of line-l0 hepatoma in nonimmune and line-l-immune guinea pigs inoculated with mixtures containing line-l0 and different numbers of line-l tumor cells a
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Nonimmune and Line-I-Immune Guinea Pigs
For comparison of the antitumor activity of a primary and anamnestic response to line-I, nonimmune and line-I-immune guinea pigs received id injections of mixtures of 3x 10 6 line-I and 10 6 line-IO tumor cells. Controls were given line-IO tumor cells alone or line-l and line-IO tumor cells at separate sites. In non immune animals, id injection at the same site of 3x 10 6 line-I and lOS line-IO cells completely suppressed tumor growth in 2 of 5 recipients, inhibited local tumor growth in 5 of 5, and significantly prolonged survival relative to all other experimental and control groups. By contrast, no inhibition of line-IO growth was observed when the same mixture was injected into line-I-immune recipients (table 2, text- fig. 3A, B) . Increasing the dose of line-l cells to 3 X 10 7 failed to influence line-IO growth in line-limmune recipients (table 3, text- fig. 4A, B) . Multiple in-jections of line-l were similarly ineffective in suppressing line-IO tumor growth in line-I-immune recipients (table  3) .
Systemic Tumor-Specific Immunity in Guinea Pigs Receiving Mixtures of Line-I and Line-I0 Cells
Animals surviving the id injection of line-l and line-IO were rechallenged with 10 6 line-IO tumor cells. Three of 5 that had received 3 X 10 7 line-I cells and 4 of 4 that had received 3X 10 6 line-I cells resisted line-IO challenge. All nonimmune controls succumbed to an id injection of lOS line-IO cells.
DISCUSSION
The line-l hepatoma is a moderately antigenic tumor that will grow in the skin of a syngeneic recipient for approximately 2 weeks and regress, leaving the animal specifically immune to rechallenge. Line-IO, by contrast, is a weakly immunogenic hepatoma that will grow progressively after id injection, metastasize to regional lymph nodes, and kill the recipient. In this report, line-IO tumor growth was suppressed when line-l cells were mixed with line-IO cells before id injection into nonimmune guinea pigs. Injection of line-l cells on the contralateral flank did not affect line-lO growth. Contact with viable tumor cells was required. Admixture with irradiated line-I cells or viable strain-2 embryo cells failed to affect line-IO grpwth. Line-IO growth was not suppressed when a mixture of line-I and line-IO cells was injected into guinea pigs immunized to line-l tumor. Earlier reports of bystander effects in vivo have described the local antitumor activity of an anamnestic response to syngeneic tumors in mice (20) and guinea pigs (19) . Growth of another guinea pig tumor, line-7, was suppressed when a mixture of line-l and line-7 cells was injected into an animal immunized to line-l tumor. Significantly less inhibition of line-7 growth occurred when a mixture of line-I and line-7 cells was injected into a nonimmune recipient. The interpretation of these experiments was complicated by the presence of multiple tumor transplants in the same animal and by an observation period limited to 2 weeks. Rejection of line-l tumor after id injection into a nonimmune guinea pig is a gradual process requiring more than a month for complete resolution. In our present study, a longer observation period and the injection of a single tumor mixture probably favored the demonstration of the antitumor activity of a primary response to line-l cells. When the intensity of delayed cutaneous reactivity in a hyperimmune recipient is considered, however, it is nO.t readily apparent why the anamnestic response should exert less bystander activity. In experiments with mycobacterial antigens, chronicity of inflammation has been a prerequisite for complete tumor suppression. Injection of living BCG into the skin of a guinea pig leads to the formation of a dermal papule that develops .central necrosis, ulcerates, and heals in 4-6 weeks. Reactions produced by living BCG completely inhibit line-IO tumor growth. Injection of PPD into animals immunized to BCG leads to intense delayed cutaneous hypersensitivity reactions persisting for 48 hours. Reactions elicited by PPD failed to suppress tumor growth completely (25) .
Nonspecific inhibition of syngeneic tumor growth was observed at reaction sites to some allogeneic murine lymphomas (16, 17) . In allogeneic reactions t(') the EL 4 lymphoma, inhibition of bystander growth was not encountered if recipients were preimmunized with EL 4 tumor cells (17) . Tanaka and Sasaki (21) reported a similar phenomenon in mice in which syngeneic fibrosarcoma growth could be suppresed at the site of a primary response to a xenogeneic rat tumor. Preimmunization with the rat tumor abrogated the local antitumor effect. The major effect of the anamnestic response in syngeneic, allogeneic, and xenogeneic systems may be to limit the duration of antigen-evoked inflammation.
In each reaction suppressing line-IO growth, the mixture of line-l and line-IO tumor cells grew into a palpable nodule that developed central necrosis, ulcerated, and healed with residual scarring. Irradiated line-l cells and a few viable line-l cells « 3 X 10 6 ) failed to produce ulcerated nodules in nonimmune recipients and to inhibit line-IO growth. Brisk delayed cutaneous reactions followed the injection of 3 X 10 6 or 3 X 10 7 line-l cells in line-I-immune hosts, but tumor nodules failed to grow, ulcerate, and regress.
Regression of id-injected line-l transplants in nonimmune guinea pigs is probably mediated by an immune response. The administration of rabbit antiserum to guinea pig lymphocytes prevents the rejection of line-l tumor.3 Intact animals that have rejected line-l cells are specifically immune to rechallenge. Line-l immunity can be transferred with peritoneal exudate cells, and once transferred, adoptive immunity can be abrogated specifically by intracardiac injection of the same tumor line (26, 27) . Judged from the ulceration observed after id injection of line-l with or without line-IO cells, the inflammatory response associated with line-l rejection can destroy normal epithelial cells, and tumor cells may also be killed as bystanders. Suppression of line-IO tumor growth could also result from augmented anti-line-IO immunity. The immune response to line-l cells might exert an adjuvant effect. In contrast is the observation that 2 of 5 animals surviving the inoculation of 3 X 10 7 line-l and 10 6 line-IO were not immune to rechallenge with line-IO tumor cells.
Line-l and line-IO cells share an embryonic antigen detectable by reaction in vitro with appropriate xenoantisera (28). This is of particular interest considering the slight, but significant, inhibition of line-IO tumor growth when line~lO cells were mixed with strain-2 embryo cells before id injection (text- fig. 2 ). Against the possibility that a shared embryonic antigen functions as a tumor-specific transplantation antigen in vivo is the fact that uniform resistance to rechallenge with line-IO was not observed in animals surviving injection of mixtures containing line-l and line-IO cells. Of greater significance are observations that line-IO cells grow at a similar rate in line-I-immune and nonimmune recipients (text-figs. 3, 4) , and that line-l tumor grows, ulcerates, and regresses at a similar rate in line-IO-immune and nonimmune guinea pigs. 4 The mechanism of bystander killing is not known. Stimulated lymphocytes, activated macrophages, and vascular damage may all contribute to the destruction of tumor cells (1) . We suggested that the rejection of syngeneic tumor grafts occurs in a series of steps (19, 25) . Initially, sensitized lymphocytes recognize distinctive tumor antigens. Subsequently, macrophages are recruited that can kill tumor cells "nonspecifically." The ,demonstration of macrophage-mediated tumor killing and inhibition of tumor growth in vitro has supported this hypothesis (11) (12) (13) (14) . Hibbs found ip injection of trypan blue (an inhibitor of macrophage function in vitro) inhibited primary and anamnestic responses to allogeneic and syngeneic tumor grafts in vivo (29, 30) . It was more difficult to abrogate anamnestic responses than primary graft rejection. Although line-IO growth at sites of line-l rejection in line-I-immune animals was not inhibited, it is possible that smaller numbers of line-IO cells would have been suppressed. Considered in this way, both primary and anamnestic responses are associated with the destruction of bystanders but larger numbers of bystanders are killed during a primary response.
